07:00 , Sep 20, 2010 |  BC Week In Review  |  Clinical News

10% high purity intravenous immunoglobulin: Phase II/III start

Next month, Octapharma will begin a double-blind, placebo-controlled Phase II/III trial to evaluate 10% high purity IVIG in 172 patients. Octapharma AG , Lachen, Switzerland   Product: 10% high purity intravenous immunoglobulin (IVIG)   Business:...
08:00 , Feb 22, 2010 |  BC Week In Review  |  Clinical News

10% high purity intravenous immunoglobulin: Phase III started

Octapharma began an international Phase III trial to evaluate 10% high purity IVIG. The company's octagam , a 5% IVIG, is marketed in about 60 countries worldwide. Octapharma AG , Lachen, Switzerland   Product: 10%...